Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer
Young Joo Min, Kwang Ro Joo, Neung Hwa Park, Tae Kwon Yun, Yang Won Nah, Chang Woo Nam, Jae Hoo Park
Korean J Intern Med. 2002;17(4):259-262.   Published online 2002 Dec 1     DOI: https://doi.org/10.3904/kjim.2002.17.4.259
Citations to this article as recorded by Crossref logo
Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
Clara Appiah, Shitian Chen, Afia Ibnat Pori, Vladimir Retyunskiy, Chimeng Tzeng, Ye Zhao
Frontiers in Pharmacology.2024;[Epub]     CrossRef
Perspectives on chemotherapy-induced toxicities in pancreatic cancer
Henu Kumar Verma, Tarun Sahu, LVKS Bhaskar
Current Cancer Reports.2024; 5: 181.     CrossRef
Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs
Sarah Brumskill, Lawrence N. Barrera, Peter Calcraft, Caroline Phillips, Eithne Costello
Journal of Physiology and Biochemistry.2023; 79(1): 223.     CrossRef
Nanocarriers targeting the diseases of the pancreas
Nurbanu Demirtürk, Erem Bilensoy
European Journal of Pharmaceutics and Biopharmaceutics.2022; 170: 10.     CrossRef
Gemcitabine-Induced Hemolytic Uremic Syndrome in Lung Cancer: A Case Report
Prashant Ahlawat, Monica Gupta, Prateek Upadhyay, Shivani Gupta, Amanjot Kaur
Cureus.2022;[Epub]     CrossRef
Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade
Abdullahi Alausa, Khadijat Ayodeji Lawal, Oluwakemi Arinola Babatunde, E.N.O. Obiwulu, Olajumoke Christianah Oladokun, Olumide Samuel Fadahunsi, Ugwu Obiora Celestine, Emmanuel Ugbede Moses, Ifunanya Rejoice Akaniro, Peter Ifeoluwa Adegbola
Pharmacological Research.2022; 181: 106264.     CrossRef
Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies
Andreia S. Fernandes, Catarina Oliveira, Rui L. Reis, Albino Martins, Tiago H. Silva
Marine Drugs.2022; 20(11): 689.     CrossRef
α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma
Caixia Liang, Tomohiko Fukuda, Tomoya Isaji, Chengwei Duan, Wanli Song, Yuqin Wang, Jianguo Gu
Biochimica et Biophysica Acta (BBA) - General Subjects.2021; 1865(6): 129870.     CrossRef
FOLFIRINOX in adjuvant and metastatic settings for pancreatic cancer in the era of precision oncology
Anda Crişan, Liliana Eleonora Semenescu, Ciprian Camil Mireştean, Adina Mitrea, Irina Roxana Iancu, Dragoş Petru Teodor Iancu
Oncolog-Hematolog.ro.2021; 1(54): 32.     CrossRef
Mechanistic Actions between Garcinia atroviridis Essential Oil and 2 Deoxy-d-glucose in Cultured PANC-1 Human Pancreatic Cancer Cells
Nik Nur Syazni Nik Mohamed Kamal, Fatin Athirah Abdul Aziz, Wen-Nee Tan, Agustine Nengsih Fauzi, Vuanghao Lim
Molecules.2021; 26(12): 3518.     CrossRef
First experience of using combination of conformal radiation therapy with intraarterial administration of gemcitabine and nanostabilized paclitaxel in patients with locally advanced pancreatic cancer complicated by persistent chronic pain
A. A. Statsenko, V. E. Moiseenko, A. V. Pavlovsky, S. A. Popov, A. A. Polikarpov, E. V. Vlasova
Medical alphabet.2020; (20): 15.     CrossRef
Inhibition of Pancreatic Cancer Cell Viability and Tumor Growth Through Cell Cycle Arrest by an Oral Formulation of Docetaxel DHP23001
Jung Ae Kang, Jung Hyu Sin, Hye Lim Lee, Hye Rim Kim, Sung Hun Kim, Min-Kyoung Kang, A-Ram Yu, Min-Hee Son, Hye-Jin Park, Jae Jun Lee
International Journal of Pharmacology.2019; 15(8): 994.     CrossRef
p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
Kai Wang, Graham S Baldwin, Mehrdad Nikfarjam, Hong He
World Journal of Gastroenterology.2018; 24(33): 3709.     CrossRef
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts
Orla Coleman, Michael Henry, Fiona O'Neill, Sandra Roche, Niall Swan, Lorraine Boyle, Jean Murphy, Justine Meiller, Neil T. Conlon, Justin Geoghegan, Kevin C. Conlon, Vincent Lynch, Ninfa L. Straubinger, Robert M. Straubinger, Gerard McVey, Michael Moriar
Proteomes.2018; 6(4): 45.     CrossRef
Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives
Mina Hosseini, Seyed Mahdi Hassanian, Elham Mohammadzadeh, Soodabeh ShahidSales, Mina Maftouh, Hasan Fayazbakhsh, Majid Khazaei, Amir Avan
Journal of Cellular Biochemistry.2017; 118(7): 1634.     CrossRef
Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-resectable pancreatic adenocarcinoma
Raj Singh, Hayden Ansinelli, Sanjeev Sharma
Journal of Radiation Oncology.2017; 6(3): 279.     CrossRef
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Aleksandra Adamska, Alice Domenichini, Marco Falasca
International Journal of Molecular Sciences.2017; 18(7): 1338.     CrossRef
Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
Kyung Hee Lee, Min Kyoung Kim, Yeol Hong Kim, Baek Yeol Ryoo, Ho Yeong Lim, Hong Suk Song, Hoon Kyo Kim, Myung Ah Lee, Seock Ah Im, Heung Moon Chang, Jae Yong Cho, Dae Young Zang, Bong Seog Kim, Jun Suk Kim
Cancer Chemotherapy and Pharmacology.2009; 64(2): 317.     CrossRef
Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study
Hawk Kim, Jae-Hoo Park, Su Jin Shin, Mee-Ja Kim, Sung-Jo Bang, Neung Hwa Park, Yang Won Nah, Chang Woo Nam, Kwang Ro Joo, Young Joo Min
Chemotherapy.2008; 54(1): 54.     CrossRef